The present application provides compounds of Formula (I) and related compositions and methods, including methods of therapy for treating
nervous system diseases and disorders, including
multiple sclerosis (MS) and
amyotrophic lateral sclerosis (ALS), and methods for
in vivo imaging of AMPA receptors or surrogates thereof in the brain. (I)